These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29109)

  • 1. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 2. 20-Methyl-prostacyclin analogs--a two stage screening procedure for biological properties.
    Gandolfi CA; Gryglewski RJ
    Pharmacol Res Commun; 1978 Nov; 10(10):885-96. PubMed ID: 366628
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal actions of carbacyclin, a stable mimic of prostacyclin.
    Whittle BJ; Steel G; Boughton-Smith NK
    J Pharm Pharmacol; 1980 Aug; 32(8):603-4. PubMed ID: 6106709
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 6. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet and other effects of carboprostacyclin--a stable prostacyclin analogue.
    Adaikan PG; Karim SM; Lau LC
    Prostaglandins Med; 1980 Oct; 5(4):307-20. PubMed ID: 7003626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].
    Boughton-Smith NK; Vane JR; Whittle BJ
    Br J Pharmacol; 1978 Mar; 62(3):413P. PubMed ID: 346130
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
    Kauffman GL; Whittle BJ; Aures D; Vane JR; Grossman MI
    Gastroenterology; 1979 Dec; 77(6):1301-6. PubMed ID: 387511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
    Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
    Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
    [No Abstract]   [Full Text] [Related]  

  • 14. A triple test for screening biological activity of prostacyclin analogues.
    Gryglewski RJ; Nicolaou KC
    Experientia; 1978 Oct; 34(10):1336-8. PubMed ID: 367809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.
    Schrör K; Darius H; Matzky R; Ohlendorf R
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):252-5. PubMed ID: 6166877
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
    Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
    Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system.
    Weeks JR
    Acta Biol Med Ger; 1978; 37(5-6):707-14. PubMed ID: 369253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
    Whittle BJ; Moncada S; Mullane K; Vane JR
    Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.